Mushtaq Ashraf

Mushtaq Ashraf serves as the Associate Clinical Research Medical Director for US Clinical Execution at Novartis since February 2022, focusing on enhancing trial performance regarding clinical quality and recruitment, while providing insights into trial documentation. Previously, Mushtaq Ashraf held the position of Medical Director for myeloid neoplasms, specializing in sabatolimab and pipeline development. In addition, Mushtaq Ashraf worked as a Regional Medical Director for Radioligand Therapy within US Medical Oncology at Novartis, and served as a Medical Oncologist at Blanchard Valley Hospital since September 2019. Mushtaq Ashraf's earlier experience includes a Medical Oncology Fellowship at the Medical University of Ohio at Toledo from July 2017 to June 2019, a role as a Hospitalist at Spectrum Health Medical Group from May 2014 to April 2018, and serving as an Internist at St. Vincent Mercy Medical Center from July 2013 to April 2014. Education was completed at Dow Medical College with a degree in M.B., B.S. in Medicine from 2000 to 2005.